期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Risk factors for the occurrence of insulinoma: a case-control study 被引量:3
1
作者 han-xiang zhan Lin Cong +2 位作者 Yu-Pei Zhao Tai-Ping zhang Ge Chen 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第3期324-328,共5页
BACKGROUND: The etiology of insulinoma is poorly understood. Few studies investigated the possible roles of environmental factors and lifestyle in the pathogenesis of insulinoma. The aim of this study is to identify r... BACKGROUND: The etiology of insulinoma is poorly understood. Few studies investigated the possible roles of environmental factors and lifestyle in the pathogenesis of insulinoma. The aim of this study is to identify risk factors associated with occurrence of insulinoma in the Chinese population. METHODS: This study consisted of 196 patients with insulinoma and 233 controls. Demographic information of the patients and controls and risk factors of the disease were analyzed. Univariate and unconditional multivariable logistic regression analyses were made to estimate odds ratios (ORs) and possible risk factors. RESULTS: Approximately 68.88% (135/196) of the patients were from rural areas in contrast to 10.30% (24/233) of the controls (P【0.0001). This difference was confirmed by the multivariate analysis (OR=4.950; 95% CI: 2.928-8.370). Family history of pancreatic endocrine tumor (OR=16.754; 95% CI: 2.125-132.057) and other cancers (OR=2.360; 95% CI: 1.052-5.291) was also related to a high-risk population of insulinoma. CONCLUSION: Rural residents or people who have a family history of pancreatic endocrine tumor and other cancers are a high-risk population of insulinoma. 展开更多
关键词 INSULINOMA risk factors case-control study family history
下载PDF
Can aspirin use reduce the risk of pancreatic cancer:an updated systematic review and meta-analysis
2
作者 Dong Wu Bin Zhou +3 位作者 Jian Yang Fa-bo Qiu San-yuan Hu han-xiang zhan 《Journal of Pancreatology》 2020年第4期201-210,共10页
Background:Chemoprevention effect of aspirin for pancreatic cancer(PC)remains unclear.Here we performed an updated systematic review and meta-analysis to investigate the real association between aspirin consumption an... Background:Chemoprevention effect of aspirin for pancreatic cancer(PC)remains unclear.Here we performed an updated systematic review and meta-analysis to investigate the real association between aspirin consumption and risk of PC.Methods:PubMed,Web of Science,EMBASE and the Cochrane Database were systematic searched to identify the potential studies.Odds ratio(ORs)with 95%confidence intervals(CIs)were applied to assess the strength of associations.Results:Thirteen studies and approximately 28,440 participants were included.Aspirin significantly reduced the incidence of PC(OR,0.82;95%CI,0.73-0.93)in case-control studies.However,the overall results did not reveal an obvious association(OR,0.92;95%CI,0.74-1.16).Both low-dose(OR=0.86)and high-dose(OR=0.80)aspirin intake showed prevention effect.In addition,low frequency(OR,0.87;95%CI,0.73-1.05)and high frequency(OR,0.84;95%CI,0.69-1.03)seemed to be equally associated with decreased risk for PC.Aspirin consumption longer than 10 years use seems to have better effect(OR,0.73;95%CI,0.51-1.04)than shorter aspirin use(OR,0.94;95%CI,0.77-1.15).Conclusions:Our study indicated that aspirin use might be associated with decreased risk of PC,especially at high doses.But we still need to be cautious when interpreting the results. 展开更多
关键词 ASPIRIN Cancer chemoprevention META-ANALYSIS Pancreatic cancer
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部